These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32047969)

  • 1. Questionnaire-guided evaluation of the effectiveness of long-term intravesical 0.2% chondroitin sulfate therapy in interstitial cystitis.
    Kocatürk H; Atasoy N; Bedir F; Altay MS; Demirdöğen ŞO; Koç E; Yilmaz S
    Int Urogynecol J; 2021 May; 32(5):1293-1298. PubMed ID: 32047969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparative analysis of intravesical sodium hyaluronate monotherapy and its combination with oral chondroitin sulfate in patietns with bladder pain syndrome/intersticial cystitis].
    Aboyan IA; Aboyan VE; Pavlov SV; Zinkovskaya OV; Pavlov DS
    Urologiia; 2019 Apr; (1):35-39. PubMed ID: 31184015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of intravesical chondroitin-sulfate and combined hyaluronic-acid/chondroitin-sulfate therapy on female sexual function in bladder pain syndrome.
    Arslan B; Gönültaş S; Gökmen E; Özman O; Avci MA; Özdemir E
    Int Urogynecol J; 2019 Nov; 30(11):1857-1862. PubMed ID: 31254047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Review and Meta-Analysis of Intravesical Hyaluronic Acid and Hyaluronic Acid/Chondroitin Sulfate Instillation for Interstitial Cystitis/Painful Bladder Syndrome.
    Pyo JS; Cho WJ
    Cell Physiol Biochem; 2016; 39(4):1618-25. PubMed ID: 27627755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome.
    Nickel JC; Hanno P; Kumar K; Thomas H
    Urology; 2012 Jun; 79(6):1220-4. PubMed ID: 22516357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combined intravesical therapy with hyaluronic acid and chondroitin for refractory painful bladder syndrome/interstitial cystitis.
    Cervigni M; Natale F; Nasta L; Padoa A; Voi RL; Porru D
    Int Urogynecol J Pelvic Floor Dysfunct; 2008 Jul; 19(7):943-7. PubMed ID: 18338095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome/interstitial cystitis.
    Gülpınar Ö; Esen B; Kayış A; Gökçe Mİ; Süer E
    Neurourol Urodyn; 2018 Jan; 37(1):257-262. PubMed ID: 28480984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective randomized controlled multicentre trial comparing intravesical DMSO and chondroïtin sulphate 2% for painful bladder syndrome/interstitial cystitis.
    Tutolo M; Ammirati E; Castagna G; Klockaerts K; Plancke H; Ost D; Van der Aa F; De Ridder D
    Int Braz J Urol; 2017; 43(1):134-141. PubMed ID: 28124536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical chondroitin sulphate for interstitial cystitis/painful bladder syndrome.
    Downey A; Hennessy DB; Curry D; Cartwright C; Downey P; Pahuja A
    Ulster Med J; 2015 Oct; 84(3):161-3. PubMed ID: 26668417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
    Chuang YC; Kuo HC
    J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter, randomized, double-blind, parallel group pilot evaluation of the efficacy and safety of intravesical sodium chondroitin sulfate versus vehicle control in patients with interstitial cystitis/painful bladder syndrome.
    Nickel JC; Egerdie RB; Steinhoff G; Palmer B; Hanno P
    Urology; 2010 Oct; 76(4):804-9. PubMed ID: 20494413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.
    Kuo HC
    Int J Clin Pract; 2013 May; 67(5):427-34. PubMed ID: 23574103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome.
    Peng YC; Yueh-Hsia Chiu S; Feng M; Liang CC
    Taiwan J Obstet Gynecol; 2020 Nov; 59(6):922-926. PubMed ID: 33218413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of endovesical hyaluronic acid/chondroitin sulfate in the treatment of Interstitial Cystitis/Painful Bladder Syndrome.
    Porru D; Cervigni M; Nasta L; Natale F; Lo Voi R; Tinelli C; Gardella B; Anghileri A; Spinillo A; Rovereto B
    Rev Recent Clin Trials; 2008 May; 3(2):126-9. PubMed ID: 18474023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness and safety of intravesical instillation treatment of interstitial cystitis/bladder pain syndrome: a systematic review and network meta-analysis of randomized controlled trials.
    Liu S; Zhang C; Peng L; Lu Y; Luo D
    Int Urogynecol J; 2021 May; 32(5):1061-1071. PubMed ID: 32886173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Clinical Efficacy and Adverse Events between Intravesical Injections of Platelet-Rich Plasma and Botulinum Toxin A for the Treatment of Interstitial Cystitis Refractory to Conventional Treatment.
    Jhang JF; Yu WR; Kuo HC
    Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical onabotulinumtoxinA injections for refractory painful bladder syndrome.
    Chung SD; Kuo YC; Kuo HC
    Pain Physician; 2012; 15(3):197-202. PubMed ID: 22622903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of intravesical ozone in interstitial cystitis by the O'Leary-Sant symptom index.
    Pires MV; de Lima CJ; Carvalho HC; Moreira LH; Fernandes AB
    Int Urogynecol J; 2023 Jul; 34(7):1437-1446. PubMed ID: 36242631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Intravesical Platelet-Rich Plasma Can Help Patients with Interstitial Cystitis/Bladder Pain Syndrome: A Comprehensive Scoping Review.
    Soliman A; Adel M; Elnagar MA; Elsonbaty S; Hefnawy AE
    Int Urogynecol J; 2024 Sep; 35(9):1735-1743. PubMed ID: 38958727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
    Lee CL; Kuo HC
    Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.